Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

17.9%

% of WDNA's 90 holdings also in CANC

31.3%

% of CANC's 48 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus CANC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in CANC
Overlap
ELI LILLY & CO 2.7% 5.4% 2.7%
BLUEPRINT MEDICINES CORP. 2.6% 2.9% 2.6%
BRIDGEBIO PHARMA, INC. 2.4% 4.5% 2.4%
AMGEN INC 1.7% 2.8% 1.7%
NOVARTIS AG 1.7% 4.3% 1.7%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to CANC
NATERA INC 3.7%
TWIST BIOSCIENCE CORP. 3.3%
NOVOZYMES A/S-B SHARES 2.9%
VERICEL CORPORATION 2.6%
VERACYTE INC 2.1%
AGIOS PHARMACEUTICALS INC 1.9%
VERTEX PHARMACEUTICALS INC 1.8%
UNITED THERAPEUTICS CORP 1.7%
ALNYLAM PHARMACEUTICALS INC 1.6%
LABCORP HOLDINGS 1.5%
WDNA Underweight Relative to CANC
ROCHE HOLDINGS LTD-SPONS ADR -5.1%
REVOLUTION MEDICINES, INC. -5.0%
ASTRAZENECA PLC -4.2%
NUVALENT, INC. CLASS A -3.9%
SUMMIT THERAPEUTICS INC -3.9%
EXELIXIS INC -3.8%
MERUS N.V. -3.2%
ZAI LAB LTD. UNSPONSORED ADR -3.0%
DAIICHI SANKYO CO LTD -2.9%
LEGEND BIOTECH CORPORATION SPONSORED -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY